biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Jun 28, 2017 11:57pm

164 Views

Post# 26417520

RE:RE:RE:so, according to the filings

just stating the facts jd, just the facts.
we could focus on the $18 and 4 maybe more that you so vehemently presented almost 2 years ago.
what was your timing on that?

Ah yes, Jekyl who said.....

1. BTI would be worth 10s of billions by now,
2. BTI would get bought out Q2 2016,
3. His pet Lithium stock would beat BTI in 2016 (it cratered)

...wants to lecture on timing and stating the facts.

LOL.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports